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httpEndovascular repair for ruptured abdominal aortic
aneurysm confers an early survival beneﬁt over open
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George A. Antoniou, MD, PhD,a,b George S. Georgiadis, MD, PhD,b Stavros A. Antoniou, MD,c
Polyvios Pavlidis, MD,a Dimitrios Maras, MD,a George S. Sfyroeras, MD, PhD, FEBVS,d
Efstratios I. Georgakarakos, MD, PhD,b andMiltos K. Lazarides, MD, FEBVS,b Athens, Alexandroupolis, and
Crete, Greece
Background: Despite the intuitive advantages of endovascular repair (EVAR) of ruptured abdominal aortic aneurysms
(AAAs), uncertainty remains about the optimal management in the absence of convincing high-quality evidence. Our
objective was to undertake a comprehensive literature review and perform a meta-analysis of outcome data of treatment
modalities for ruptured AAAs.
Methods: Systematic searches were conducted of electronic information sources to identify studies comparing perioperative
outcomes of EVAR and open repair for AAA rupture. Summary estimates of odds ratios (ORs) or standardized mean
difference and 95% conﬁdence intervals (CIs) were obtained with a random-effects model. Meta-regression models were
formed to explore potential heterogeneity as a result of changes in practice over time.
Results:We selected 41 studies for analysis. The entire meta-analysis population comprised 59,941 patients (8201 EVAR
patients and 51,740 open repair patients). EVAR was associated with a signiﬁcantly lower incidence of in-hospital
mortality (OR, 0.56; 95% CI, 0.50-0.64; P < .01; meta-analysis of risk-adjusted observational studies and randomized
controlled trials: OR, 0.58; 95% CI, 0.46-0.73; P < .01). EVAR patients had a signiﬁcantly decreased risk of developing
respiratory complications (OR, 0.59; 95% CI, 0.49-0.69; P < .01) and acute renal failure (OR, 0.65; 95% CI, 0.55-0.78;
P < .01) and a trend toward a reduced incidence of cardiac complications (OR,L0.02; 95% CI,L0.03 to 0.00; P[ .05)
and mesenteric ischemia (OR, 0.66; 95% CI, 0.44-1.00; P [ .05). Patients treated with EVAR had signiﬁcantly
less requirements of intraoperative blood transfusion (standardized mean difference, L0.88; 95% CI, L1.06 to L0.70;
P < .01). Random-effects meta-regression revealed no statistical evidence for an association between death and year
of publication (P [ .19).
Conclusions: Our analysis provides evidence to motivate the adoption of an EVAR-ﬁrst policy in a nonelective setting and
the establishment of standardized protocols for the management ruptured AAAs. (J Vasc Surg 2013;58:1091-105.)A plethora of cohort studies, randomized trials, and
meta-analyses have provided sufﬁcient evidence demon-
strating an early survival advantage of elective endovascular
treatment for abdominal aortic aneurysms (AAAs) over
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://dx.doi.org/10.1016/j.jvs.2013.07.109data, models of service delivery have undergone reconﬁgu-
ration in several countries to accommodate optimum
elective AAA services.3 In recent years, considerable specu-
lation about the relative merits of applying endovascular
techniques for the treatment of ruptured AAA has been re-
ﬂected in the establishment of standardized protocols for
the management of this critical condition in the emergency
setting by several institutions.
Despite the intuitive advantages of endovascular aneu-
rysm repair (EVAR) related to less physiologic insult to
a critically ill patient presenting with ruptured AAA, insuf-
ﬁcient quantiﬁcation of the role of EVAR in the care
pathway for these patients exists. Single-center cohort,
multicenter cohort, and population-based studies have
revealed a trend toward a survival beneﬁt of emergency
EVAR for ruptured AAA.4,5 Our objective was to under-
take a comprehensive literature review and deﬁne the effect
of EVAR on the management of AAA rupture by conduct-
ing an analysis of the perioperative outcomes of such treat-
ment compared with conventional surgical repair.1091
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Eligibility criteria. The methods of analysis and inclu-
sion criteria were prespeciﬁed in a protocol. Studies
comparing perioperative outcomes of endovascular and
open repair of ruptured infrarenal or juxtarenal AAA were
considered for analysis. All types of comparative studies,
including prospective or retrospective, observational studies,
or randomized controlled trials (RCTs) were included.
Studies not speciﬁcally deﬁning ruptured AAA were arbi-
trarily presumed to have conﬁrmed the presence of AAA
rupture on preoperative computed tomography imaging,
by visualization of blood outside the aortic lumen into the
retroperitoneal space or the peritoneal cavity (contained or
free rupture), or intraoperatively during on-table angiog-
raphy or laparotomy. Studies reporting patients with acute
or symptomatic aneurysm without clearly stating the pres-
ence of rupture were excluded.
Types of interventions included conventional endo-
aneurysmorrhaphy with tube or bifurcated grafts through
a transperitoneal or retroperitoneal approach and standard
EVAR with bifurcated grafts or an aortouniiliac device,
followed by femorofemoral crossover bypass. Studies
describing endovascular treatments of complex aneurysms
with the chimney technique or with fenestrated or
branched grafts were not considered.
The primary outcome measure was deﬁned as the in-
hospital or 30-day mortality of any cause. Secondary
outcome end points were common perioperative complica-
tions (cardiac and respiratory complications, acute renal
impairment, mesenteric and lower limb ischemia, and
development of abdominal compartment syndrome),
requirements for intraoperative blood transfusion, and the
hospital length of stay.
Information sources and search strategy. Studies
were identiﬁed by searching electronic bibliographic data-
bases and scanning reference lists of articles. The search
was applied to MEDLINE from the time of the ﬁrst report
of endovascular treatment of ruptured AAA by Yusuf et al6
in 1994 to the present date. Unfortunately, language
constraints were applied because of lack of funding for
translation; thus, only English and German language arti-
cles were considered.
The following Expanded Medical Subject Headings
(MeSH) and keywords were combined with Boolean oper-
ators: “aortic rupture” or “aortic aneurysm rupture” or
“ruptured aortic aneurysm” and “EVAR” or “endovascular
repair” or “open repair.” Relevant articles were retrieved,
and the reference lists were manually interrogated as part
of a second-level search. A supplementary search of related
articles suggested by the PubMed search engine was con-
ducted. The literature search protocol and retrieval of the
full text of related articles was conducted in cooperation
with a librarian at the University of Athens. The last search
was on May 6, 2013.
Methods of data synthesis and analysis. Eligibility
assessment and data collection was performed by a single
reviewer in consultation with and cross-checked by twoother reviewers. A data extraction sheet (based on the
Cochrane Consumers and Communication Review
Group’s data extraction template) was pilot-tested on the
three most recent studies and reﬁned accordingly. Infor-
mation extracted from each study can be grouped into (1)
that related to the study design and characteristics (ﬁrst
author, year of publication, patient recruitment period,
type of study, and inclusion/exclusion criteria for patient
enrollment); (2) data related to clinical and demographic
characteristics of the study populations, including age, sex,
presence of hypertension, coronary artery disease, diabetes
mellitus, chronic obstructive pulmonary disease (COPD),
chronic renal insufﬁciency, and hemodynamic instability;
and (3) outcome parameters, as outlined above.
The methodologic quality of the included observa-
tional studies was ascertained with the Newcastle-Ottawa
scale (NOS),7 and the Jadad scale was applied for the
assessment of RCTs. This assessment tool evaluates three
main methodologic elements of case-control studies: selec-
tion methods (adequate case deﬁnition, representativeness
of the cases, appropriate selection, and deﬁnition of
controls), comparability of cases and controls on the basis
of the design or analysis, and assessment of exposure (ascer-
tainment of exposure, nonresponse rate). The scale uses
a star system, with a maximum of nine stars; studies
achieving $6 stars were considered to be of higher quality.
Individual study odds ratios (ORs) and 95% conﬁdence
intervals (CIs) were calculated from event numbers
extracted from each study before data pooling. In calcula-
tion of the OR, the total number of patients assigned in
each group was used as the denominator. Summary esti-
mates of ORs were obtained with a random effects model.
For continuous variables, the standardized mean difference
or difference in means and corresponding 95% CI were
computed using the random-effects model. The percentage
of variability across studies attributable to heterogeneity
beyond chance was estimated with the I2 statistic. Potential
publication bias was assessed with the Egger test and repre-
sented graphically with Begg funnel plots of the natural log
of the OR vs its standard error.8
Sensitivity analyses were performed to assess the contri-
bution of each study to the pooled estimate by excluding
individual studies one at a time and recalculating the
pooled OR estimates for the remaining studies. Separate
meta-analyses of risk-adjusted observational studies for in-
hospital (or 30-day) mortality and RCTs were undertaken.
Acceptable risk-adjustment methods included propensity
score analyses and multivariate logistic regression models.
We explored potential heterogeneity in estimates with
univariate meta-regression to identify trends in the treat-
ment effects over time and by comparing summary results
obtained from subsets of studies grouped by study design
and quality. A two-sided P value of < .05 was regarded
as signiﬁcant for all analyses. Analyses were performed
using the Review Manager 5.2 software (The Nordic
Cochrane Centre, The Cochrane Collaboration, Copenha-
gen, Denmark) and the Comprehensive Meta-Analysis 2.0
Fig 1. Flow chart shows the strategy used for the literature search. AAA, Abdominal aortic aneurysm.
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done in accordance with the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA)
guidelines.9
RESULTS
Literature search results and study characteristics.
The search of the electronic bibliographic databases identi-
ﬁed 5089 records, of which 44 were reviewed in full text.
Studies reporting mixed outcome data of treatments in
symptomatic and ruptured AAA, those containing overlap-
ping populations, studies not in English or German, and
those reporting inadequate data for analysis were excluded,
leaving 32 potentially eligible studies. In one study, incon-
sistency between values in the abstract and main text was
noticed; therefore, we decided not to include it in our
analysis. An additional 10 studies were identiﬁed during
scrutiny of the bibliographies of the included articles,
providing 41 studies for meta-analysis.10-50 Fig 1 shows
the ﬂow diagram of study selection.
The entire meta-analysis population comprised 59,941
patients, 8201 of whom underwent EVAR and the re-
maining 51,740 had an open repair of their ruptured
AAA. The studies selected for analysis were published
between 2002 and 2013, whereas the patient recruitment
period extended from 1990 to 2011. Two RCTs were
identiﬁed, with the remaining reports being single-center
or multicenter prospective or retrospective observational
studies or population-based reports. The study characteris-
tics and inclusion and exclusion criteria for patient enroll-
ment are presented in Table I. The methodologic quality
of the RCTs, represented in the Jadad score, was low. Simi-
larly, a small proportion of the observational studiesachieved a NOS score >6 (nine of 39 studies). Main demo-
graphic and clinical features of the study populations are
outlined in Table II. The perioperative complications
were ill-deﬁned and inconsistently reported among the
studies (Table III).
Synthesis of results and outcome
In-hospital mortality. All 41 studies reported data of
the primary outcome parameter set for the meta-analysis.
In-hospital mortality occurred in 30% of patients treated
with EVAR and in 42% of the patients who underwent
open repair (OR, 0.56; 95% CI, 0.50-0.64; P < .01).
Signiﬁcant heterogeneity among the studies was identiﬁed
(I2 ¼ 36%), and the likelihood of publication bias was low
(P ¼ .11; Fig 2).
Cardiac complications. Twenty studies reported
cardiac complications. The incidence of such complications
was 14% in the EVAR group and 16% in the open repair
group (OR, 0.02; 95% CI, 0.03 to 0.00; P ¼ .05).
No signiﬁcant heterogeneity was found among the studies
(I2 ¼ 28%), and the possibility of publication bias was low
(P ¼ .76; Fig 3).
Respiratory complications. Data regarding perioper-
ative respiratory complications were reported in 19
studies. Patients undergoing EVAR had a signiﬁcantly
decreased risk of developing a respiratory complication
compared with patients treated with open repair (6% vs
11%; OR, 0.59; 95% CI, 0.49-0.69; P < .01). No signif-
icant heterogeneity among the studies existed (I2 ¼ 22%),
and the chance of publication bias was low (P ¼ .27;
Fig 3).
Acute renal failure. Eight studies reported incidences
of acute renal impairment during the perioperative period.
Table I. Study characteristics
First author/year Study period Type of study Total patients (No.) EVAR Open repair
Park/2013 2005-2009 Population-based retrospective study 16,557 3796 12,761
Reimerink/2013 2004-2011 RCT 116 57 59
Nedeau/2012 2000-2010 Hospital-based retrospective study 74 19 55
Noorani/2012 2006-2010 Hospital-based retrospective study 102 52 50
Saqib/2012 2001-2010 Hospital-based retrospective study 148 37 111
Mayer/2012 1998-2009 Hospital-based retrospective study 361 198 163
Mandawat/2012 2003-2007 Population-based retrospective study 271 64 207
Ioannidis/2012 2003-2008 Hospital-based retrospective study 43 20 23
Sarac/2011 1990-2008 Hospital-based retrospective study 160 32 128
Holt/2010 2003-2008 Population-based retrospective study 4414 335 4079
Starnes/2010 2007-2009 Hospital-based prospective observational study 51 27 24
Bosch/2010 2002-2008 Hospital-based prospective observational study 58 25 33
Chagpar/2010 2003-2008 Hospital-based retrospective study 167 32 135
Lyons/2010 2006-2007 Hospital-based retrospective study 37 18 19
Davenport/2010 2005-2007 Population-based retrospective study 427 99 328
Giles/2009 2000-2005 Population-based retrospective study 28,429 2323 26,106
Vun/2009 2004-2008 Hospital-based retrospective study 45 7 38
Verhoeven/2009 2002-2009 Hospital-based retrospective study 159 45 114
Vogel/2009 2001-2005 Population-based retrospective study 700 82 618
Visser/2009 2004-2006 Multicenter prospective observational study 201 58 143
Giles/2009 2005-2007 Population-based retrospective study 567 121 446
Veith/2009 1994-2008 Hospital-based retrospective study 57 45 12
Wibmer/2008 2003-2006 Hospital-based retrospective study 47 16 31
Lee/2008 2002-2006 Hospital-based retrospective study 37 17 20
Sharif/2007 2001-2006 Hospital-based observational study 126 52 74
Ockert/2007 2000-2005 Hospital-based retrospective study 58 29 29
Anain/2007 2001-2006 Hospital-based observational study 40 30 10
Acosta/2007 2000-2004 Hospital-based retrospective study 162 56 106
Greco/2006 2000-2003 Population-based retrospective study 5798 290 5508
Coppi/2006 1999-2006 Hospital-based observational study 124 33 91
Hinchliffe/2006 2002-2004 RCT 32 15 17
Peppelenbosch/2006 2003-2004 Multicenter prospective observational study 100 49 51
Dalainas/2006 1998-2005 Hospital-based observational study 28 20 8
Larzon/2005 2001-2004 Hospital-based retrospective study 41 15 26
Alsac/2005 2001-2004 Hospital-based observational study 37 17 20
Vaddineni/2005 1999-2004 Hospital-based retrospective study 24 9 15
Brandt/2005 2003-2004 Hospital-based retrospective study 24 11 13
Lee/2004 2002-2004 Hospital-based retrospective study 17 13 4
Reichart/2003 2000-2002 Hospital-based retrospective study 19 6 13
Resch/2003 2001-2002 Hospital-based observational study 37 14 23
Yilmaz/2002 1999-2001 Hospital-based observational study 46 17 29
AAA, Abdominal aortic aneurysm; CT, computed tomography; EVAR, endovascular aneurysm repair; NOS, Newcastle-Ottawa Scale; NR, not reported;
RCT, randomized controlled trial; TAAA, thoracoabdominal aortic aneurysm; US, ultrasound.
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Inclusion criteria Exclusion criteria NOS/Jadad score
NR Age <60 years 6
CT conﬁrmed ruptured AAA suitable for both EVAR
and open repair
Juxta-/suprarenal AAA, kidney transplant, horseshoe
kidney, allergy to intravenous contrast, connective
tissue disease, severe hemodynamic instability
prohibiting CT
3
NR Aortic neck <5 mm, diameter larger than the largest
available main body graft, severe iliac arterial occlusive
disease
7
Conﬁrmed rupture NR 7
CT or intraoperatively conﬁrmed ruptured AAA Antecedent AAA repair, symptomatic AAA without
rupture, incomplete medical reports
6
NR Ruptured TAAA, ruptured isolated iliac aneurysms 5
Patients with ruptured AAA transferred for treatment
from other hospitals
Thoracic/TAAA aortic dissection 5
Ruptured AAA (including rupture after EVAR and
rupture with penetrating ulcers)
Ruptured thoracic and AAAs 5
NR Reoperative AAA, juxtarenal AAA, TAAA, isolated iliac
artery aneurysms, symptomatic but not ruptured AAA
7
NR NR 6
NR NR 6
CT conﬁrmed ruptured AAA suitable for EVAR NR 6
CT or intraoperatively conﬁrmed ruptured AAA NR 6
NR Symptomatic but not ruptured AAA 6
NR NR 6
NR NR 6
CT or intraoperatively conﬁrmed ruptured AAA NR 5
CT or intraoperatively conﬁrmed ruptured AAA Acute nonruptured AAA 6
NR NR 5
CT or intraoperatively conﬁrmed ruptured AAA NR 6
NR NR 6
NR NR 6
NR Congenital connective tissue disease-related ruptured
AAA, secondary rupture (after preceding elective
repair)
7
CT or intraoperatively conﬁrmed ruptured AAA Aneurysms involving the origin of the renal/visceral
vessels
5
CT or intraoperatively conﬁrmed ruptured AAA NR 6
US or CT or angiographically or intraoperatively
conﬁrmed ruptured AAA
Symptomatic but not ruptured AAA, ruptured TAAA,
ruptured traumatic aneurysms
7
CT or intraoperatively conﬁrmed ruptured AAA Symptomatic but not ruptured AAA 6
CT or intraoperatively or autopsy conﬁrmed ruptured
AAA
Nonruptured inﬂammatory or symptomatic AAA 5
NR NR 6
NR Symptomatic but not ruptured AAA 7
Patients with ruptured AAA considered suitable for
open repair, patients stable enough to undergo CT
Endovascular team/device unavailable, age <50 years,
inability to give consent, unconscious patient, allergy to
contrast, stainless steel, polyester; severe comorbidity,
previous EVAR, women of child-bearing potential,
pregnant/lactating women
2
CT or intraoperatively conﬁrmed ruptured AAA Life expectancy <1 year, not consenting to participate 8
NR NR 6
NR NR 7
CT or intraoperatively conﬁrmed ruptured AAA
(including noninfected aortic pseudoaneurysms and
ruptured AAA previously treated with EVAR)
Symptomatic but not ruptured AAA, mycotic AAA or
infected aortic pseudo-aneurysms, post-traumatic
aneurysms, TAAA
8
CT or intraoperatively conﬁrmed ruptured AAA NR 6
CT or intraoperatively conﬁrmed ruptured infrarenal
AAA
NR 5
Ruptured infra-renal AAA Isolated iliac artery aneurysms 5
NR No pre-operative CT 6
NR NR 6
NR NR 6
Table I. Continued.
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Table II. Demographic and clinical characteristics of study populations
First author/
year
EVAR vs open repair
Mean age
(year)
Male gender
(%)
Hypertension
(%)
Coronary
artery
disease (%)
Diabetes
mellitus (%) COPD (%)
Chronic renal
insufﬁciency
(%)
Hemodynamic
instability (%)
Park/2013 NR 75 vs 75 55 vs 47 32 vs 25 16 vs 12 35 vs 34 18 vs 14 NR
Reimerink/2013 75 vs 75 86 vs 85 23 vs 17 28 vs 24b 4 vs 2 12 vs 5 2 vs 3 11 vs 14
Nedeau/2012 78 vs 76 74 vs 61 74 vs 66 53 vs 38 16 vs 13 26 vs 24 42 vs 9e 50 vs 57
Noorani/2012 78 vs 71a NR 45 vs 42 39 vs 32 6 vs 4 21 vs 10 4 vs 4 NR
Saqib/2012 75 vs 76 70 vs 62 82 vs 87 57 vs 64 41 vs 33 27 vs 31 8 vs 15 24 vs 44
Mayer/2012 74 vs 72 85 vs 87 NR NR NR NR NR 41 vs 34
Mandawat/2012 NR NR NR NR NR NR NR NR
Ioannidis/2012 70 vs 72 95 vs 100 50 vs 57 35 vs 48b 10 vs 13 20 vs 17 30 vs 30f NR
Sarac/2011 81 vs 72 66 vs 77 72 vs 80 66 vs 64 25 vs 16 41 vs 44 25 vs 23 NR
Holt/2010 NR NR NR NR NR NR NR NR
Starnes/2010 NR 85 vs 71 67 vs 86 54 vs 48 13 vs 10 29 vs 38 33 vs 14 67 vs 79
Bosch/2010 72 vs 74 88 vs 97 NR 64 vs 73d 12 vs 12 28 vs 18 42 vs 27g 56 vs 54
Chagpar/2010 76 vs74a 75 vs 75 69 vs 72 22 vs 11 26 vs 19 44 vs 24 NR NR
Lyons/2010 76 vs 76a 100 vs 68 NR 50 vs 26 NR 33 vs 26 11 vs 26h NR
Davenport/2010 72 vs 74 80 vs 77 NR 9 vs 6 NR 19 vs 13 1 vs 2 NR
Giles/2009 75 vs 73 78 vs 78 52 vs 44 28 vs 22 10 vs 9 30 vs 32 2 vs 1 NR
Vun/2009 NR 86 vs 74 NR NR NR NR NR NR
Verhoeven/2009 NR NR NR NR NR NR NR NR
Vogel/2009 NR NR NR NR NR NR NR NR
Visser/2009 73 vs 74 93 vs 83 50 vs 42 21 vs 25c 14 vs 9 26 vs 21 14 vs 11 7 vs 28
Giles/2009 73 vs 74 80 vs 76 64 vs 71 35 vs 27 15 vs 11 21 vs 15 2 vs 1i NR
Veith/2009 NR NR NR NR NR NR NR NR
Wibmer/2008 76 vs 69a 75 vs 84 81 vs 55 56 vs 52 25 vs 7 25 vs 34 50 vs 38j 13 vs 55
Lee/2008 NR 59 vs 65 NR NR NR NR NR 47 vs 75
Sharif/2007 NR NR NR NR NR NR NR 23 vs 50
Ockert/2007 71 vs 71a 72 vs 97 79 vs 79 28 vs 24 NR 17 vs 10 14 vs 21 48 vs 48
Anain/2007 NR NR NR NR NR NR NR 50 vs 60
Acosta/2007 76 vs 74a 80 vs 85 NR NR NR NR NR 34 vs 54
Greco/2006 NR NR 50 vs 49 33 vs 24 15 vs 10 25 vs 31 7 vs 7 NR
Coppi/2006 81 vs 77a 85 vs 81 87 vs 73 69 vs 55b 18 vs 11 69 vs 30 6 vs 15 45 vs 63
Hinchliffe/2006 74 vs 80 73 vs 76 33 vs 47 20 vs 29 NR 0 vs 18 7 vs 12 47 vs 35
Peppelenbosch/
2006
75 vs 74 86 vs 80 NR 18 vs 16b NR 29 vs 25 14 vs 22 43 vs 43
Dalainas/2006 NR NR NR NR NR NR NR NR
Larzon/2005 NR NR NR NR NR NR NR NR
Alsac/2005 73 vs 73 94 vs 100 53 vs 60 18 vs 20 6 vs 10 41 vs 20 18 vs 5 NR
Vaddineni/2005 71 vs 72 71 vs 75 NR NR NR NR NR 0 vs 40
Brandt/2005 NR NR NR NR NR NR NR NR
Lee/2004 NR NR NR NR NR NR NR NR
Reichart/2003 NR NR NR NR NR NR NR NR
Resch/2003 79 vs 73 79 vs 87 71 vs 56 26 vs 35c NR 14 vs 26 14 vs 13 36 vs 74%
Yilmaz/2002 NR NR NR NR NR NR NR NR
COPD, chronic obstructive pulmonary disease; EVAR, endovascular aneurysm repair; NR, not reported.
aMedian value.
bCardiac disease.
cPrevious myocardial infarction.
dCardiovascular comorbidity.
eGlomerular ﬁltration rate <60 mL/min/1.73 m2.
fSerum creatinine >1.7 mg/dL.
gSerum creatinine >140 mg/dL.
hSerum creatinine >90 mmol/L.
iOn dialysis.
jSerum creatinine >1.5 mg/dL.
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developing renal failure than patients undergoing open
AAA repair (16% vs 26%; OR, 0.65; 95% CI, 0.55-0.78;
P < .01). Signiﬁcant heterogeneity among the studieswas identiﬁed (I2 ¼ 43%), and the possibility of publication
bias was low (P ¼ .76; Fig 3).
Acute lower limb ischemia. Eight studies reported
rates of acute limb ischemia, with an incidence of 3%
Table III. Deﬁnitions of perioperative complications
First author/
year
Cardiac
complications
Respiratory
complications
Acute renal
failure
Acute limb
ischemia
Mesenteric
ischemia
Abdominal
compartment
syndrome
Park/2013 MI ND ND ND ND NR
Reimerink/2013 ND NR Temporary or
permanent
dialysis or
permanent renal
insufﬁciency
NR ND NR
Nedeau/2012 Cardiovascular
complications
Respiratory/
infectious
complications
NR NR NR NR
Noorani/2012 NR NR NR NR NR Requiring
laparotomy
Saqib/2012 MI Respiratory failure
requiring
>7 days of
ventilatory
support
Requiring dialysis ND ND NR
Mayer/2012 MI ND ND ND ND NR
Mandawat/2012 NR NR NR NR NR NR
Ioannidis/2012 MI Pneumonia ND NR Requiring bowel
resection
ND
Sarac/2011 MI Postoperative
intubation
period
>48 hours,
need for
reintubation,
positive sputum
culture,
radiographically
conﬁrmed
pneumonia
Serum creatinine
>1.8 mg/dL or
increase of
>50% of
baseline
creatinine value
NR ND ND
Holt/2010 NR NR NR NR NR NR
Starnes/2010 NR NR NR NR NR NR
Bosch/2010 Cardiac arrest
or MI
ND NR NR NR NR
Chagpar/2010 NR NR NR NR NR ND
Lyons/2010 ND ND ND NR ND ND
Davenport/2010 MI Pneumonia ND NR ND ND
Giles/2009 MI NR ND NR NR NR
Vun/2009 ND ND ND ND ND NR
Verhoeven/2009 NR NR NR NR NR NR
Vogel/2009 NR NR NR Requiring
reintervention
Requiring
reintervention
Requiring
reintervention
Visser/2009 NR NR NR NR NR NR
Giles/2009 NR NR NR NR NR NR
Veith/2009 NR NR NR NR NR NR
Wibmer/2008 ND ND ND NR NR NR
Lee/2008 NR NR NR NR NR NR
Sharif/2007 MI ND ND NR NR NR
Ockert/2007 NR NR NR NR NR NR
Anain/2007 MI Pneumonia ND ND ND ND
Acosta/2007 NR NR NR NR NR Requiring
reintervention
Greco/2006 ND ND ND NR ND NR
Coppi/2006 ND ND Requiring dialysis NR ND NR
Hinchliffe/2006 NR ND ND NR ND ND
Peppelenbosch/
2006
ND ND ND ND NR ND
Dalainas/2006 NR NR NR NR NR NR
Larzon/2005 ND ND ND NR NR NR
Alsac/2005 MI ND ND ND ND ND
Vaddineni/2005 NR NR NR NR NR NR
Brandt/2005 NR NR NR NR NR NR
(Continued on next page)
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Table III. Continued.
First author/
year
Cardiac
complications
Respiratory
complications
Acute renal
failure
Acute limb
ischemia
Mesenteric
ischemia
Abdominal
compartment
syndrome
Lee/2004 NR NR NR NR NR NR
Reichart/2003 NR NR NR NR NR NR
Resch/2003 NR NR NR NR NR NR
Yilmaz/2002 NR NR NR NR NR NR
MI, Myocardial infarction; ND, not deﬁned; NR, not reported.
Fig 2. Forest plot shows comparison of in-hospital mortality among the studies in the meta-analysis. CI, Conﬁdence
interval; EVAR, endovascular aneurysm repair; M-H, Mantel-Haenszel.
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0.63; 95% CI, 0.37-1.07; P ¼ .09). Signiﬁcant heteroge-
neity among the studies was found (I2¼ 60%), and the like-
lihood of publication bias was low (P ¼ .76; Fig 3).
Mesenteric ischemia. Rates of mesenteric ischemia
were reported in 15 studies. A trend was found toward
a lower incidence of mesenteric ischemia developing
among patients treated with EVAR than in those under-
going open repair (4% vs 6%; OR, 0.66; 95% CI, 0.44-
1.00; P ¼ .05). Signiﬁcant heterogeneity among the
studies was found (I2 ¼ 69%), and the possibility of publi-
cation bias was low (P ¼ .91; Fig 3).Abdominal compartment syndrome. Data regarding
abdominal compartment syndrome was reported in 12
studies. The incidence of abdominal compartment
syndrome was 9% in the EVAR group and 8% in the
open repair group (OR, 1.06; 95% CI, 0.56-2.03; P ¼
.85). Signiﬁcant heterogeneity among the studies existed
(I2 ¼ 34%), and the chance of publication bias was low
(P ¼ .12; Fig 3).
Secondary interventions. Fourteen studies reported
data related to secondary interventions within the perioper-
ative period. The incidence of such interventions was 16%
in the EVAR group and 21% in the open repair group
Fig 3. Forest plot of comparison of (a) cardiac complications, (b) respiratory complications, (c) acute renal failure, (d)
lower limb ischemia, (e) mesenteric ischemia, (f) abdominal compartment syndrome, (g) secondary interventions, (h)
intraoperative blood transfusion, and (i) hospital length of stay among the studies in the meta-analysis. CI, Conﬁdence
interval; EVAR, endovascular aneurysm repair; M-H, Mantel-Haenszel; IV, inverse variance; SD, standard deviation.
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Fig 3. Continued
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heterogeneity among the studies (I2 ¼ 0%), and the likeli-
hood of publication bias was low (P ¼ .59; Fig 3).
Intraoperative blood transfusion. Data regarding
the amount of intraoperative blood transfusion suitable
for meta-analysis were reported by ﬁve studies. Patients
treated with EVAR had signiﬁcantly less requirements of
intraoperative blood transfusion than patients undergoing
open AAA repair (standardized mean difference, 0.88;
95% CI, 1.06 to 0.70; P < .01). There was no
heterogeneity among the studies (I2 ¼ 0%), and the
possibility of publication bias was low (P ¼ .63; Fig 3).
Hospital length of stay. Only four studies reported
appropriate data on the hospital length of stay to enterthe meta-analysis models. Although these studies found
a trend toward a shorter hospital stay in the EVAR group,
our analysis found no signiﬁcant difference between the
groups (mean difference, 3.28; 95% CI, 8.18 to 1.61;
P ¼ .19). Signiﬁcant heterogeneity among the studies
existed (I2 ¼ 65%), and the likelihood of publication bias
was high (P ¼ .02; Fig 3).
Sensitivity and meta-regression analyses
The combined outcome estimate of mortality was not
substantially affected when the primary analysis was
repeated with altered data sets after excluding each single
study at a time. Furthermore, the effect of EVAR on in-
hospital mortality was not different in hospital-based
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Fig 4. Scatterplot shows the relationship between year of publication of the studies in the meta-analysis and log odds
ratio (OR) for mortality (random-effects meta-regression, P ¼ .19).
Fig 5. Forest plot shows comparison of adjusted in-hospital mortality among the studies in the meta-analysis. CI,
Conﬁdence interval; EVAR, endovascular aneurysm repair; IV, inverse variance; SE, standard error.
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analysis, P ¼ .19 for interaction). Random-effects meta-
regression revealed little or no statistical evidence for an
association between the log OR for mortality and year of
publication (P ¼ .19; Fig 4).
Eleven observational studies provided adjusted ORs for
in-hospital mortality. Adjustment was performed for several
confounding variables, which varied among the studies. The
log OR and the standard error were calculated from the
adjusted OR and 95% CI and entered in a separate
random-effects meta-analysis model (Fig 5). The ORs of
the two RCTs were put in the model as well. Analysis
revealed that EVARwas associated with a signiﬁcantly lower
mortality than open repair (OR, 0.58; 95% CI, 0.46-0.73;
P < .01 for effect, P ¼ .04 for heterogeneity; I2 ¼ 46%).
DISCUSSION
Concurrent progress in experience and technology in
critical care and anesthetic settings during the last decades
has not been accompanied by similar improvements inmortality rates of conventional treatment for ruptured
AAA.51 Widespread adoption of endovascular approaches
for the elective treatment of AAAs is consistent with solid
evidence demonstrating early survival advantages over
surgical repair and reﬂects a paradigm shift in management
practice of aortic aneurysmal disease.1-3 However, the
optimal treatment of ruptured AAA remains controversial
in the absence of convincing high-level evidence from
randomized trials. The perceived beneﬁts of EVAR for
ruptured AAA are supported by several observational
studies that reveal a trend toward improved outcomes
with this approach compared with open repair and are
depicted in the increasing establishment of EVAR proto-
cols by several institutions worldwide. Our objective was
to collect the world experience in the endovascular treat-
ment of AAA rupture and consolidate existing evidence
by conducting a meta-analysis of outcome data.
In the current meta-analysis comprising data of
w60,000 patients, comparisons of early mortality between
EVAR and open treatment groups revealed a substantial
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ruptured AAA. These results are mainly based on observa-
tional reports, which are inevitably afﬂicted by publication
and patient selection bias, with only two RCTs being iden-
tiﬁed. Furthermore, the methodologic quality of the
studies varied, and clinical parameters, such as hemody-
namic instability at presentation, are inconsistently re-
ported. The heterogeneity among the studies regarding
in-hospital mortality may also be explained by centers
with different volumes providing data for analysis and by
the variable application of speciﬁc management protocols
of patients presenting with ruptured AAA. Therefore,
because of the heterogenous study characteristics at the
patient and study design level, the pooled estimate of in-
hospital mortality should be cautiously interpreted.
However, the consistency of this outcome advantage in
favor of EVAR among almost all of the studies included
in the analysis demonstrates the robustness of our ﬁndings.
In the setting of nonrandomized comparisons,
various confounding variables, such as comorbid condi-
tions and the presence of hemodynamic instability, may
have an effect on the pooled outcome estimate. Several
authors have argued that stable patients, whose hemody-
namic and physiologic condition permits performance of
computed tomography to ascertain the anatomic suit-
ability for EVAR, are preferentially treated with an endo-
vascular approach compared with cardiovascularly
compromised patients presenting in severe shock, who
are taken to the operating theater straightaway for
surgical aortic cross-clamping without any preoperative
imaging investigation.52
In an attempt to circumvent such limitations, separate
meta-analysis models were formed to include RCTs and
studies providing risk adjustments for several factors that
might potentially have an effect on the overall outcome.
Our ﬁnding was validated by such analyses, providing
further evidence for the use of EVAR as a ﬁrst-line treat-
ment for this critical clinical condition. Unfortunately,
the studies selected for analysis did not discriminate
patients presenting with hemodynamic instability; there-
fore, subgroup analyses could not be conducted. However,
most studies that provided risk-adjusted outcome data per-
formed adjustments for hemodynamic instability, and the
survival beneﬁt of EVAR over open repair persisted even
after adjustment for this confounding factor.
Furthermore, sensitivity analyses and subgroup meta-
regression comparing outcome measures in hospital-based
and population-based reports consistently demonstrated
survival superiority of EVAR over open surgical repair of
AAA rupture. Even though selective reporting of studies
with positive results can seriously bias conclusions, we
found no statistical evidence to prove publication bias in
almost all of the outcome variables examined.
We further investigated the comparative effectiveness
of treatments by exploring differences in main morbidity
parameters accompanying ruptured AAA repair. Patients
undergoing EVAR were less likely to develop respiratory
complications, acute renal impairment, and mesentericischemia, reﬂecting differences in the physiologic effects
of a major abdominal operation compared with a minimally
invasive endovascular aortic procedure. Furthermore, our
analysis did not substantiate previous concerns of increased
risk of abdominal compartment syndrome in patients
receiving EVAR in the presence of a large retroperitoneal
or intraperitoneal hematoma. Other factors, such as visceral
edema and ﬂuid shifts resulting from aortic cross-clamping,
increased requirements for blood transfusion, and acute
inﬂammatory response might contribute to the develop-
ment of the syndrome, which requires a secondary
intervention.53,54
In all but one synthesis (hospital length of stay), the
likelihood of publication bias was low. Analytic tools
(Begg funnel plot and Egger test) were used to quantify
the potential presence of publication bias; nevertheless,
forms of reporting bias cannot be exclusively excluded,
and the results of our analysis should be cautiously
interpreted.
CONCLUSIONS
Our analysis provides robust outcome data to enhance
and motivate the widespread adoption of an EVAR-ﬁrst
policy in a nonelective setting. Ruptured AAAs might be
best managed within institutions with a large aortic work-
load. Centers with instituted protocols are likely to have
superior outcomes with endovascular management of
ruptured AAA; therefore, implementing such protocols at
high-volume centers is recommended. Implementation of
speciﬁc management protocols should be illustrated in
a multidisciplinary approach involving specialized endovas-
cular, radiologic, vascular critical care, and anesthetic
teams. Establishment of institutional protocols involves
systemic changes in the health care delivery infrastructure,
with around-the-clock availability of endovascular devices
and auxiliaries along with skilled specialists and nursing
teams. The ability to establish institutional protocols also
includes the requirement for adequate on-the-shelf stock,
usually consigned to the hospital. Although a move toward
an endovascular-ﬁrst approach may be beneﬁcial, wide-
spread adoption may not be feasible presently in larger
countries with rural communities. Procedural costs for
EVAR are higher, and many smaller hospitals may not
have the ability to maintain an on-the-shelf stock of these
costly devices to reasonably adopt the EVAR-ﬁrst
approach.
Improvements in outcomes as a result of constantly
evolving stent graft designs and endovascular techniques,
in tandem with increased endovascular experience, might
be expected in the future. The converse should also be
noted, namely, the eventual erosion of open surgical tech-
nique as trainees are involved in fewer and fewer open AAA
cases.
Meta-regression analysis investigating potential effects
of the publication date of each study on perioperative
mortality in the treatment groups did not explain heteroge-
neity as a result of changes in practice over time. More
conclusive results from large RCTs are expected.
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term outcomes of EVAR for ruptured AAA are available.
The selected studies did not provide patient group strat-
iﬁcation according to the proportion of patients that was
transferred to another facility before open or endovascular
management. Such data may help determine whether the
proximity of a tertiary care facility would signiﬁcantly affect
the primary end point and should be a potential ﬁeld for
further research. For example, the availability of stent grafts
is more likely in a center with a high volume of endoluminal
aortic surgery. The hemodynamic stability of the patient,
surgeon preference and experience, and anatomic suitability
for EVAR might also signiﬁcantly affect which method of
repair was chosen in the studies included in the analysis.
Areas for future research constitute the identiﬁcation of
poor prognostic factors related to EVAR performed in the
acute setting and the establishment of risk-prediction
models to direct preferential treatment management of
this critical clinical condition.
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